ctnm: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	19,220	115
Net increase in cash and cash equivalents	20,690	-1,159
Cash and cash equivalents at beginning of period	21,943	-
Cash and cash equivalents at end of period	42,633	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	19,220	115
Net increase in cash and cash equivalents	20,690	-1,159
Cash and cash equivalents at beginning of period	21,943	-
Cash and cash equivalents at end of period	42,633	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Contineum Therapeutics, Inc. (CTNM)